1-4 of 4
Sarah K. Tasian
Close
Sort by
Journal Articles

CD38 as a pan-hematologic target for chimeric antigen receptor T cells

Tina Glisovic-Aplenc, Caroline Diorio, John A. Chukinas, Kimberly Veliz, Olga Shestova, Feng Shen, Selene Nunez-Cruz, Tiffaney L. Vincent, Fei Miao, Michael C. Milone, Carl H. June, David T. Teachey, Sarah K. Tasian, Richard Aplenc, Saar Gill
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4418–4430.
https://doi.org/10.1182/bloodadvances.2022007059
Published: 2023
Includes: Supplemental data
Journal Articles

Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia

Clinical Trials & Observations
Richard C. Harvey, Sarah K. Tasian
Journal: Blood Advances
Blood Adv (2020) 4 (1): 218–228.
https://doi.org/10.1182/bloodadvances.2019000163
Published: 2020
Journal Articles

Opportunities for immunotherapy in childhood acute myeloid leukemia

Adam J. Lamble, Sarah K. Tasian
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3750–3758.
https://doi.org/10.1182/bloodadvances.2019000357
Published: 2019
Journal Articles

A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study

Clinical Trials & Observations
Sarah Wagner, Jayakumar Vadakekolathu, Sarah K. Tasian, Heidi Altmann, Martin Bornhäuser, A. Graham Pockley, Graham R. Ball, Sergio Rutella
Journal: Blood Advances
Blood Adv (2019) 3 (8): 1330–1346.
https://doi.org/10.1182/bloodadvances.2018030726
Published: 2019
Includes: Supplemental data